Follow-The-Filings

Security

Arrivent Biopharma Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

10 owners max 0.9% (Hsg Holding Ltd)

owners 10
max % 0.9%
tracked value $104M
qoq A 5 R 3

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Hsg Holding Ltd 2026 Q1 0.9% 663,308 $14M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Add +0.02 pp 748,195 $17M hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Add +0.01 pp 426,281 $10M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 368,795 $9M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 1,869,266 $38M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 425,923 $10M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 166,157 $4M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 77,479 $2M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce 0.00 pp 35,165 $811 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 15,923 $367 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$80.49M -$166.31M
Net margin

Balance sheet

Metric FY2024 FY2025
Total current assets $226.98M $332.9M
Total non-current assets * $47.96M $272,000
Total assets $274.94M $333.17M
Total current liabilities $17.27M $25.94M
Total non-current liabilities * $14,000 $0.00
Total equity $257.65M $307.22M

Cash flow

Metric FY2024 FY2025
Cash from operations -$70.21M -$160.59M
Cash from investing -$192.46M -$71.23M
Cash from financing $186.58M $203.06M
Net change in cash -$76.1M -$28.75M

ownership over time

filing count by report period · click a bar for that quarter’s holders